ELV
Elevance Health, Inc.
NYSE · Healthcare · Medical - Healthcare Plans · US
$422.02
+1.84%Oct 23, 2026, 15:00 UTC
Elevance Health, Inc. reported nine-month profit of $4.6 billion, down from $5.1 billion in the same period a year earlier, and a benefit expense ratio of 90.6%.
Source:Oct 21, 2026, 20:46 UTC
Elevance Health, Inc. shares reached a fresh 52-week high.
Source:Oct 21, 2026, 19:15 UTC
BJC HealthCare and Washington University in St. Louis will leave the Aetna, Inc. and Elevance Health, Inc. Medicare Advantage networks on January 1, 2027, after contract negotiations failed.
Source:Oct 21, 2026, 17:00 UTC
Elevance raised its 2026 earnings guidance after reporting better-than-expected third-quarter results.
Source:Oct 21, 2026, 16:21 UTC
Elevance Health, Inc. raised its 2026 underlying earnings baseline to $26.75.
Source:Oct 21, 2026, 11:30 UTC
Elevance Health, Inc. announced Jeff Park’s appointment as President of Carelon, effective December 1, 2026.
Source:Oct 21, 2026, 10:00 UTC
Elevance Health reported third-quarter 2026 results ahead of expectations.
Oct 14, 2026, 08:30 UTC
The Federation of State Medical Boards convened a 22-member workgroup to develop guidelines for state regulation of medical AI, with recommendations to be opened for feedback before formal adoption.
Source:Oct 4, 2026, 12:30 UTC
UnitedHealth Group, Elevance Health, and AHIP sponsored the MAHA Summit held on Tuesday, September 29, 2026, to gain a seat at the table in the MAHA movement's health policy discussions.
Source:Oct 2, 2026, 03:30 UTC
Baltimore Healthy Start opened a new West Baltimore office at the Bethel Empowerment and Wellness Center on McCulloh Street, its first dedicated office presence in West Baltimore in more than 10 years.
Source:Oct 1, 2026, 11:00 UTC
Elevance Health announced that its affiliated health plans will offer 2027 Medicare Advantage plans featuring expanded choice, simpler benefit experiences and more coordinated member support.
Source:Sep 19, 2026, 20:15 UTC
Connecticut Comptroller Sean Scanlon's office announced new AI regulations on September 16 covering the state employee health plan and the Connecticut Partnership Plan, prohibiting insurers from using AI as the sole basis for down-coding claims or reducing payments, effective January 1, 2027.
Source:Sep 18, 2026, 18:00 UTC
Healthy Blue, owned by Elevance Health, will stop providing Medicaid coverage in Louisiana beginning January 1, 2027, forcing about 290,000 members to choose a new plan.
Source:Sep 10, 2026, 18:13 UTC
Elevance Health Inc. reaffirmed its full-year 2026 earnings guidance ahead of a series of investor meetings.
Source:Sep 10, 2026, 12:45 UTC
Iowa Republican candidate Zach Lahn said he would maintain private management of Iowa's Medicaid program if elected governor, while Democratic candidate Rob Sand said he would begin undoing private management on his first day in office.
Source:Aug 17, 2026, 10:06 UTC
Barden Capital Management Inc. acquired a new stake in Elevance Health, Inc. during the second quarter, purchasing 1,609 shares valued at approximately $622,000.
Source:Aug 17, 2026, 08:55 UTC
Avise Financial Cooperative Inc. acquired a new stake in Elevance Health, Inc. (NYSE: ELV), purchasing 1,633 shares valued at approximately $632,000, as disclosed in its Form 13F filing with the SEC.
Source:Aug 13, 2026, 07:36 UTC
Ballast Inc. acquired a new stake in Elevance Health, Inc. by purchasing 1,572 shares valued at approximately $608,000, as disclosed in a recent SEC filing.
Source:Jul 15, 2026, 17:12 UTC
Elevance Health announced on its second-quarter earnings call that it plans to further shrink its Medicaid portfolio over the next 12 to 18 months, exiting markets it deems unsustainable.
Source:Jul 15, 2026, 10:28 UTC
Elevance Health declared a quarterly dividend of $1.72 per share, up $0.01 from the prior year.
Source:Jul 15, 2026, 10:00 UTC
Elevance Health reported its second quarter 2026 financial results.
Jul 2, 2026, 18:34 UTC
Elevance Health filed a lawsuit against the U.S. government in the U.S. District Court for the Southern District of Georgia, alleging that federal efforts to recalculate its Medicare Advantage quality ratings did not align with a recent court ruling, costing the insurer $115 million.
Source:Jun 26, 2026, 18:30 UTC
Elevance Health paid $342 million to the U.S. Centers for Medicare & Medicaid Services to settle allegations of overbilling the Medicare Advantage program, following a CMS enforcement action that threatened to halt enrollments.
Source:Jun 25, 2026, 11:30 UTC
CNSide Diagnostics, a subsidiary of Plus Therapeutics, signed a national coverage agreement with Elevance Health to provide the CNSide CSF TCE assay to approximately 45.4 million people in the United States.